IL6 and endothelial dysfunction: Taken together, these head-to-head data support an important conclusion: IL-6 is more informative during the ultra-early phase of disease [24,36], whereas Ang-2 provides superior accuracy and clinical relevance for predicting persistent organ failure and endothelial dysfunction–related complications during the subsequent phase [31,32,33,34,35,36].